The dangerous liaison: Coronary and kidney disease

Abstract

Get full access to this article

View all access options for this article.

References

National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classiﬁcation, and stratiﬁcation. Am J Kidney Dis 2002; 39(Suppl 1): S1–S266.

Shulman

Ford

Hall

et al.

Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group. Hypertension 1989; 13(Suppl): I80–I93.

Foley

Parfrey

Sarnak

. Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 1998; 9(Suppl): S16–S23.

Foley

Parfrey

Sarnak

. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998; 32(Suppl 3): S112–S119.

Sarnak

Levey

. Cardiovascular disease and chronic renal disease: A new paradigm. Am J Kidney Dis 2000; 35(Suppl 1): S117–S131.

Keith

Nichols

Gullion

et al.

Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 2004; 164: 659–663.

Levey

Beto

Coronado

et al.

Controlling the epidemic of cardiovascular disease in chronic renal disease. What do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. Am J Kidney Dis 1998; 32: 853–906.

Hillege

Fidler

Diercks

et al.

for the Prevention of Renal and Vascular End Stage Disease (PREVEND) Study Group. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 2002; 106: 1777–1782.

Wagner M, Wanner C, Kotseva K et al. Prevalence of chronic kidney disease and its determinants in coronary heart disease patients in 24 European countries – insights from the EUROSPIRE IV survey of the european society of cardiology. Eur J Prev Cardiol 2017; 24:1168–1180.